The role of allogeneic hematopoietic cell transplantation for chronic lymphocytic leukemia: A review
Although the use of allogeneic hematopoietic cell transplantation (HCT) for chronic lymphocytic leukemia (CLL) has declined with the development of novel targeted agents, it continues to play an important role for eligible patients with high-risk or heavily pretreated CLL who lack other treatment op...
Main Authors: | Robert Puckrin, Mona Shafey, Jan Storek |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-01-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2022.1105779/full |
Similar Items
-
Immune reconstitution after hematopoietic stem cell transplantation
by: Justyna Ogonek, et al.
Published: (2016-11-01) -
Editorial: Immune Tolerance Post Allogeneic Hematopoietic Cell Transplantation
by: Dominik Schneidawind, et al.
Published: (2020-03-01) -
MRD as Biomarker for Response to Donor Lymphocyte Infusion after Allogeneic Hematopoietic Cell Transplantation in Patients with AML
by: Katrin Teich, et al.
Published: (2023-08-01) -
Bone marrow GvHD after allogeneic hematopoietic stem cell transplantation
by: Martin eSzyska, et al.
Published: (2016-03-01) -
The impact of regulatory T cells on the graft-versus-leukemia effect
by: Carolina P. Pacini, et al.
Published: (2024-04-01)